N-terminal pro-brain natriuretic peptide in the elderly with myocardial infarction.
BACKGROUND
The myocardial infarction (MI) results in the change of the levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) in blood. In addition, attention is paid to the dependence of NT-proBNP levels on the patients' age. However, the behavior of natriuretic peptide levels has not been recognized well enough in the elderly with MI treated with invasive methods.


OBJECTIVE
The aim of the study was to estimate the effect of age on NT-proBNP levels in patients with first MI, and treated with primary percutaneous coronary intervention (PCI) with complete coronary revascularization.


METHODS
One hundred and sixty-one consecutive patients with first ST-elevation MI, and treated with primary PCI with stent implantation (occlusion in infarct-related artery was the patient's only lession) were included. Determination of NT-proBNP level and echocardiography were performed on the 4th-5th day of MI.


RESULTS
Thirty-seven patients (23%) aged>or=65 y were considered as a study group. The NT-proBNP levels were nearly 4-fold higher in older patients than in younger patients. Only systolic and diastolic dysfunction, mitral regurgitation, troponin T levels, and glomerular filtration rate (GFR) were independent risk factors of the occurrence of elevated NT-proBNP concentration above median.


CONCLUSIONS
The patients' age was not a factor independently affecting the increase of NT-proBNP level above the median in patients with first MI and treated successfully with primary PCI. Independently associated elevated levels of NT-proBNP were as follows: presence of diastolic dysfunction, mitral regurgitation, left ventricular systolic dysfunction, troponin T concentration, and GFR.
Szadkowska
Iwona
I
Invasive Cardiology Unit, Department of Cardiology, Medical University of Lodz, Lodz, Poland. iwonakoska@interia.pl
Goch
Jan Henryk
JH
Kawiński
Janusz
J
Chizyński
Krzysztof
K
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000503:physiopathology / Q000628:therapy; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D015607:Stents
D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain
Hypertension. 2005 Jul;46(1):118-23
15939804
Eur Heart J. 2005 Jun;26(11):1115-40
15901669
Eur Heart J. 2000 Sep;21(18):1514-21
10973765
Am Heart J. 2002 May;143(5):923-9
12040359
N Engl J Med. 2004 Feb 12;350(7):647-54
14960741
Am J Cardiol. 2004 Apr 15;93(8):1002-6
15081443
Am J Cardiol. 2005 Apr 15;95(8):948-54
15820160
Clin Chim Acta. 2005 Nov;361(1-2):167-75
15993397
Clin Chem Lab Med. 2004;42(12):1430-3
15576307
Circulation. 2003 Jun 10;107(22):2786-92
12771003
Circulation. 2004 Jul 13;110(2):128-34
15197143
Circulation. 2002 Feb 5;105(5):595-601
11827925
Eur Heart J. 2005 Apr;26(8):804-47
15769784
Eur J Heart Fail. 2001 Jan;3(1):91-6
11163741
Am Heart J. 2004 Jun;147(6):1078-84
15199359
Eur J Echocardiogr. 2006 Mar;7(2):79-108
16458610
J Am Coll Cardiol. 2003 Apr 16;41(8):1264-72
12706919
Circulation. 1996 Jun 1;93(11):1963-9
8640969
Am Heart J. 1998 Jan;135(1):21-8
9453517
N Engl J Med. 2001 Oct 4;345(14):1014-21
11586953
Heart. 1999 Feb;81(2):114-20
9922344